• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体的分子模拟。I. A1受体上的配体结合位点。

Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

作者信息

IJzerman A P, Van Galen P J, Jacobson K A

机构信息

Center for Bio-Pharmaceutical Sciences, Division of Medicinal Chemistry, Leiden, The Netherlands.

出版信息

Drug Des Discov. 1992;9(1):49-67.

PMID:1457698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3440871/
Abstract

The amino acid sequence of the canine adenosine A1 receptor and the atomic coordinates of a structurally related protein, bacteriorhodopsin, were combined to generate a three-dimensional model for the adenosine A1 receptor. This model consists of seven amphipathic alpha-helices, forming a pore that has a rather distinct partition between hydrophobic and hydrophilic regions. Subsequently, a highly potent and selective ligand, N6-cyclopentyladenosine, was docked into this cavity. A binding site is proposed that takes into account the conformational characteristics of the ligand, obtained from indirect modeling studies by the 'active analog approach'. Moreover, it involves two histidine residues that were shown to be important for ligand coordination from chemical modification studies. Finally, the deduced binding site was used to model other potent ligands that could all be accommodated consistent with earlier biochemical and pharmacological findings.

摘要

犬腺苷A1受体的氨基酸序列与结构相关蛋白细菌视紫红质的原子坐标相结合,生成了腺苷A1受体的三维模型。该模型由七个两亲性α螺旋组成,形成一个在疏水和亲水区域之间有相当明显分隔的孔。随后,一种高效且选择性的配体N6-环戊基腺苷被对接至该腔内。提出了一个结合位点,该位点考虑了通过“活性类似物方法”的间接建模研究获得的配体构象特征。此外,它涉及两个组氨酸残基,化学修饰研究表明这两个残基对配体配位很重要。最后,推导得到的结合位点被用于对其他强效配体进行建模,这些配体都能与早期的生化和药理学研究结果一致地容纳。

相似文献

1
Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.腺苷受体的分子模拟。I. A1受体上的配体结合位点。
Drug Des Discov. 1992;9(1):49-67.
2
Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.腺苷受体的分子建模。大鼠腺苷A2A受体上的配体结合位点。
Eur J Pharmacol. 1994 Jun 15;268(1):95-104. doi: 10.1016/0922-4106(94)90124-4.
3
Cloning and functional characterization of a human A1 adenosine receptor.
Biochem Biophys Res Commun. 1992 Sep 16;187(2):919-26. doi: 10.1016/0006-291x(92)91285-x.
4
Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.作为定制配体性质设计策略的三功能试剂:A1腺苷受体的不可逆抑制剂
Bioconjug Chem. 1991 Mar-Apr;2(2):77-88. doi: 10.1021/bc00008a002.
5
Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.G蛋白偶联受体的建模:应用于多巴胺、肾上腺素、血清素、乙酰胆碱和哺乳动物视蛋白受体。
J Med Chem. 1992 Sep 18;35(19):3448-62. doi: 10.1021/jm00097a002.
6
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.2-氨基-3-苯甲酰基噻吩对腺苷A1受体结合及功能的变构增强作用
Mol Pharmacol. 1990 Dec;38(6):939-49.
7
A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition.A1腺苷受体。两种氨基酸导致了配体识别的物种差异。
J Biol Chem. 1994 Nov 11;269(45):27900-6.
8
Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.大鼠脑膜中A1腺苷受体的化学修饰。配体结合位点不同结构域中组氨酸的证据。
J Biol Chem. 1988 Nov 25;263(33):17522-6.
9
Role of the second transmembrane domain of rat adenosine A1 receptor in ligand-receptor interaction.
Biochem Pharmacol. 2006 Mar 14;71(6):865-71. doi: 10.1016/j.bcp.2005.12.013. Epub 2006 Jan 18.
10
An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.一种用于研究内源性腺苷/A1受体相互作用在体内作用的实验范式。
J Pharmacol Exp Ther. 1992 Nov;263(2):657-62.

引用本文的文献

1
The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors.双功能二聚体咖啡因-茚满可减轻慢性刺激腺苷 A1 受体后 α-突触核蛋白错误折叠、神经退行性变和行为缺陷。
Int J Mol Sci. 2024 Aug 29;25(17):9386. doi: 10.3390/ijms25179386.
2
Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System.乌利吉诺辛B,一种可能的新型镇痛药,通过调节腺苷能系统发挥作用。
Evid Based Complement Alternat Med. 2016;2016:5890590. doi: 10.1155/2016/5890590. Epub 2016 Mar 21.
3
Transporter Protein-Coupled DPCPX Nanoconjugates Induce Diaphragmatic Recovery after SCI by Blocking Adenosine A1 Receptors.转运蛋白偶联的DPCPX纳米缀合物通过阻断腺苷A1受体诱导脊髓损伤后膈肌恢复。
J Neurosci. 2016 Mar 23;36(12):3441-52. doi: 10.1523/JNEUROSCI.2577-15.2016.
4
Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.基于结构的 G 蛋白偶联腺苷和 P2Y 受体配体方法,从小分子到纳米缀合物。
J Med Chem. 2013 May 23;56(10):3749-67. doi: 10.1021/jm400422s. Epub 2013 May 9.
5
Probing GPCR structure: adenosine and P2Y nucleotide receptors.探索GPCR结构:腺苷和P2Y核苷酸受体
Methods Enzymol. 2013;520:199-217. doi: 10.1016/B978-0-12-391861-1.00009-5.
6
Molecular Characterization of A(1) and A(2a) Adenosine Receptors.A(1)和A(2a)腺苷受体的分子特征
Drug Dev Res. 1993 Mar;28(3):226-231. doi: 10.1002/ddr.430280307. Epub 2004 Oct 5.
7
Molecular Architecture of G Protein-Coupled Receptors.G蛋白偶联受体的分子结构
Drug Dev Res. 1996 Jan 1;37(1):1-38. doi: 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S.
8
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).功能化同系物方法设计 G 蛋白偶联受体 (GPCR) 的配体。
Bioconjug Chem. 2009 Oct 21;20(10):1816-35. doi: 10.1021/bc9000596. Epub 2009 Apr 30.
9
A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor.一种以血栓素A2受体的核磁共振肽结构为模板构建前列环素受体配体识别口袋的策略。
BMC Biochem. 2005 Nov 4;6:23. doi: 10.1186/1471-2091-6-23.
10
Exploring the molecular basis of selectivity in A1 adenosine receptors agonists: a case study.探索A1腺苷受体激动剂选择性的分子基础:一项案例研究。
J Comput Aided Mol Des. 2003 Jan;17(1):39-51. doi: 10.1023/a:1024530029922.

本文引用的文献

1
A simple method for displaying the hydropathic character of a protein.一种展示蛋白质亲水性特征的简单方法。
J Mol Biol. 1982 May 5;157(1):105-32. doi: 10.1016/0022-2836(82)90515-0.
2
A comprehensive set of sequence analysis programs for the VAX.一套适用于VAX的综合序列分析程序。
Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95. doi: 10.1093/nar/12.1part1.387.
3
Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists.人成纤维细胞中腺苷受体的激活:核苷激动剂和拮抗剂
Can J Physiol Pharmacol. 1980 Jun;58(6):673-91. doi: 10.1139/y80-110.
4
Subclasses of external adenosine receptors.外周腺苷受体的亚类。
Proc Natl Acad Sci U S A. 1980 May;77(5):2551-4. doi: 10.1073/pnas.77.5.2551.
5
The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.腺苷及腺嘌呤核苷酸对豚鼠大脑皮层切片中3',5'-环磷酸腺苷含量的影响。
Mol Pharmacol. 1970 Jan;6(1):13-23.
6
Adenosine analogs with covalently attached lipids have enhanced potency at A1-adenosine receptors.具有共价连接脂质的腺苷类似物在A1-腺苷受体上具有增强的效力。
FEBS Lett. 1987 Dec 10;225(1-2):97-102. doi: 10.1016/0014-5793(87)81138-9.
7
Purine receptors in mammalian tissues: pharmacology and functional significance.哺乳动物组织中的嘌呤受体:药理学及功能意义
Annu Rev Pharmacol Toxicol. 1987;27:315-45. doi: 10.1146/annurev.pa.27.040187.001531.
8
N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.N6-(芳基烷基)腺苷。N6-(9-芴基甲基)腺苷作为腺苷A2受体的高效激动剂的鉴定。
J Med Chem. 1988 Jan;31(1):271-3. doi: 10.1021/jm00396a044.
9
2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors.
Eur J Pharmacol. 1988 Oct 26;156(1):157-60. doi: 10.1016/0014-2999(88)90158-6.
10
Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.大鼠脑膜中A1腺苷受体的化学修饰。配体结合位点不同结构域中组氨酸的证据。
J Biol Chem. 1988 Nov 25;263(33):17522-6.